Ankylosing spondylitis
News from the FDA/CDC
FDA approves upadacitinib (Rinvoq) for sixth indication
Upadacitinib’s approval for nonradiographic axial spondyloarthritis marks the sixth indication in the United States for the Janus kinase inhibitor...
From the Journals
Who are the patients with longstanding ankylosing spondylitis without syndesmophytes?
A small minority of patients with longstanding ankylosing spondylitis and fused sacroiliac joints lack syndesmosphytes, and these patients were...
Feature
Breakthrough COVID studies lend support to use of new boosters in immunosuppressed patients
The findings of two studies underscore the importance of booster vaccine doses in those with immune-mediated inflammatory diseases who are taking...
Conference Coverage
Sex differences seen in inflammatory arthritis health care use
Women’s higher risk of conditions such as osteoarthritis and pain and fatigue may help to explain why overall healthcare resource use was higher...
Conference Coverage
Hormones’ impact described in transgender rheumatology patients
Gender-affirming hormone therapy does not need to be a strict contraindication in transgender patients with rheumatic disease, an author of a new...
Conference Coverage
Around 10% of back pain patients referred by chiropractors have undiagnosed SpA
“Chiropractors need education for axSpA, when to suspect, and when to refer.”
Conference Coverage
Spondyloarthritis disease activity measurement with ASDAS not influenced by gender
Researchers studied how gender affects the reporting of patient outcomes across commonly used scoring methods and indices in the spectrum of...
Conference Coverage
Filgotinib reduces flare risk in uveitis in phase 2 study
Phase 2 data on filgotinib show a reduction in risk of flare in patients with uveitis and good tolerance in one of the first studies of a JAK...
Conference Coverage
COX-2, TNF inhibitor combo appear to have limited role in reducing axSpA spinal damage progression
Despite no statistical significance, there was a strong numerical signal of reduction in spinal structural damage of adding in a selective COX-2...
Conference Coverage
Bimekizumab effective for axSpA with or without prior TNFi treatment
Data after 24 weeks of treatment with bimekizumab in patients with nonradiographic and radiographic axial spondyloarthritis show good responses in...
Conference Coverage
AI algorithm detects erosions, ankylosis with high accuracy in patients with sacroiliitis
Preliminary data from an AI algorithm designed to detect erosions and ankylosis in patients with sacroiliitis show nearly 90% accuracy and is...